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Abstract. – OBJECTIVE: It is biologically 
plausible that occupational and environmental 
pesticide exposure may contribute to breast 
cancer risk. Persistent chemical compounds, 
such as pesticides, tend to be lipophilic and are 
detected in human breast milk and adipose tis-
sue. Therefore, the present systematic review 
aims to clarify the gender difference in breast 
cancer concerning pesticide exposure. 
MATERIALS AND METHODS: A total of 70 
studies satisfied the inclusion criteria and were 
included in the systematic review. 
RESULTS: From the studies analyzed, it was 
observed that exposure to pesticides could be 
a risk factor for breast cancer in women, in par-
ticular in young women and in women who ex-
perienced menarche at a young age. In con-
trast, no association was found for breast can-
cer in men. Female breast cancer is correlated 
with estrogen receptor-negative tumor charac-
teristics. Breast cancer in men was no correlat-
ed with pesticide exposure.
CONCLUSIONS: Breast cancer in women has 
been linked to estrogen receptor positivity, but 
this positivity appears to be inversely related 
to fertility. The estrogen-like effects of organo-
chlorine pesticides could be the cause of the ob-
served gender differences.
Key Words:
Breast neoplasm, Mammary cancer, Breast tumor, 
Endocrine disruptors, Environmental exposure, Occu-
pational exposure.
Introduction
Breast cancer (BC) is a group of diseases 
in which cells of the breast tissue change and 
divide in an uncontrolled manner, characteris-
tically resulting in a lump or mass1, consisting 
of four primary molecular subtypes and at least 
21 different histological subtypes that differ in 
risk factors, staging, response to treatment, and 
outcomes1.
Worldwide, there were approximately 2.1 mil-
lion newly diagnosed female breast cancer (FBC) 
cases during 20182. In the same year, more than 
600,000 women died from FBC2.
Hereditary and genetic factors are the most fre-
quent risk factors in FBC, including an individual 
or familial history of FBC and/or ovarian cancer 
and inherited mutations (i.e., BRCA1, BRCA2, 
and further breast cancer susceptibility genes). 
Other known risk factors for FBC are connected 
with menstruation (early age at menarche, age at 
menopause), reproduction (nulliparity, late age at 
first at childbirth, and fewer children), exogenous 
hormone intake (oral contraceptive use and hor-
mone surrogate therapy), diet (alcohol intake), an-
thropometry (higher weight, weight gain during 
adulthood, and body fat distribution), shift work, 
and various occupational and environmental risk 
factors3-12; while breastfeeding and physical ac-
tivity are recognized as protective factors3.
BC is a pathology that can also affect men13. 
Male breast cancer (MBC) is infrequent, repre-
senting 1% of cancers that happen in men and 
approximately 1% of all BC worldwide14-18. Fewer 
than 0.2% of cancer-related deaths in men can be 
attributed to MBC19,20. 
However, the incidence and prevalence of 
MBC fluctuate by race and ethnicity13. Indefi-
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nite male populations, such as African Amer-
icans, have elevated rates of MBC in contrast 
with equivalent Caucasian, Hispanic, or Asian/
Pacific Islander populations13. The median age 
at BC diagnosis is characteristically higher in 
men than in women, at 68 and 62, respective-
ly13. 
The first identification of MBC frequently oc-
curs at a later stage than in FBC. MBC is often 
further advanced at the instance of identification 
and may include, for example, a superior cancer 
dimension, lymph node involvement, and remote 
metastases14,15,21-26.
Genetic risk factors for MBC are similar, but 
not identical, to those in women. Family history 
is pertinent for both21,22, and BRCA2 mutations 
and rearrangements play an important role in 
MBC23-26. Between 5-10% of men with BRCA2 
mutations can develop BC27-31. However, one in-
vestigation32 of 102 Italian MBC patients estab-
lished no BRCA1 or BRCA2 reorganizations. 
Circumstances that modify the ratio of estro-
gen to androgen have been connected to MBC. 
Klinefelter’s syndrome33,34, exogenous estrogen 
or testosterone use35, obesity34,36-38, orchitis/epi-
didymitis34, finasteride39,40, and prostate cancer 
treated with estrogens, have been linked with 
MBC41. Participating in sports appears to de-
crease risk34. Some investigations have not estab-
lished an association between smoking, alcohol 
intake, and MBC34,38. Epidemiological studies 
have evaluated occupational exposure, as well as 
exposure to electromagnetic fields42-43, heat44, and 
polycyclic aromatic hydrocarbons, pesticides, and 
other chemicals45-47 as possible risk factors for 
MBC. However, the data have been varied and 
questionable48,49. 
It is biologically plausible that occupational 
and environmental exposure may contribute to 
BC risk; in particular, persistent chemical com-
pounds (i.e., pesticides) tend to be lipophilic and 
are detected in human breast milk and adipose 
tissue50-52. As an endocrine disruptor, pesticide 
exposure may cause BC by altering hormonal ac-
tivity or causing epigenetic damage53. Therefore, 
the present systematic review aims to clarify the 
gender differences in BC with regard to pesticide 
exposure.
Materials and Methods
This systematic review was carried out in ac-
cordance with the PRISMA statement54.
Literature Search
SCOPUS, Medline (using PubMed as the 
search engine), Embase, and Web of Science 
databases were examined to identify relevant re-
search available until November 1, 2020, to inves-
tigate the association between pesticide exposure 
and BC, with BC as the principal outcome.
A MeSH term was used with the following 
entry terms: “Breast Neoplasms” AND “Pesti-
cides”; “Breast Neoplasms” AND “Agrochemi-
cals”; “Breast Neoplasms” AND “Pesticide Res-
idues”.
A search for research manuscripts that were 
appropriate for inclusion in this systematic re-
view was conducted, and the papers of signifi-
cance therein were collected and reviewed.
Inclusion and Exclusion Criteria
The subsequent inclusion criteria were as-
sumed: (1) studies that assessed BC in relation 
to pesticide exposure assessments. The following 
exclusion criteria were applied: (1) animal stud-
ies, (2) scientific articles that are not published in 
the English language; and (3) reviews, conference 
abstracts or letters to the editor.
For matching studies, only articles with sup-
plementary detailed information were included.
Quality Assessment and Data Extraction
Two reviewers (CL and VR) recovered articles 
independently. The title, abstract, and full text 
of each potentially relevant study was reviewed. 
Any divergence on the eligibility of the papers 
was determined through debate or by consulting 
an additional reviewer (MB). The following in-
formation was extracted from all papers: authors, 
year of publication, exposure, study design, pe-
riod, population observed, age population ob-
served, country, and conclusion of the study.
Results
Characteristics of Eligible Studies
After a search of the scientific literature by the 
reviewers, 312 research papers were collected, 
and five were replicated. A total of 307 were 
investigated following a review of the title and 
abstract, and 237 studies were deemed ineligible 
after reviewing the manuscript. In summary, 70 
studies satisfied the inclusion criteria and were 
included in the systematic review55-121. A flow-
chart showing the choice of studies is presented 
in Figure 1. 
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Researchers from various countries conduct-
ed the investigations: 35 in the USA; four each 
in Canada, Spain, and the UK; three each in 
Australia, Brazil, Canada, China, and Denmark; 
two each in Belgium, Germany, Japan, Italy, 
and Mexico; and one each in Colombia, Egypt, 
France, Greece, India, the Netherlands, Norway, 
Palestine, Sweden, Switzerland, and Taiwan Fig-
ure 2).
The study designs were as follows: 43 case-con-
trol, 12 cohorts, eight mortality cohort, six inci-
dence cohort, two ecological, and one observa-
tional study.
To highlight gender differences, it was decided 
to divide the studies between FBC (Table I) and 
MBC (Table II).
Female Breast Cancer
The studies included 63 articles that aimed to 
establish an association between FBC and pesti-
cide exposure. The studies were performed over 
a long period: 1960-2019. In recent years, the pes-
ticides used have varied considerably; some have 
not been available for a long time, while others 
have been introduced to the market more recently. 
Furthermore, pesticides are persistent pollutants 
in the environment, and current exposure may be 
affected by remote exposure because of residual 
contamination in some areas of the globe50.
A total of 13 (21%) studies investigated work-re-
lated exposure in women55,58,64,65,67,69,75-78,88,107,112, 
46 (73%) investigated environmental expo-
sure56,57,59-63,66,68,71-74,79,81,83-87,89-104,106,108-111,113-118, 
and four (6%) investigated both exposure fac-
tors70,80,82,105.
A total of 25 studies analyzed pesti-
cide metabolites in serum and BC inciden
ce56,57,60-63,66,68,72-74,81,92,96,98,104,108,110,111,116-118, and five 
measured the concentrations of pesticides (me-
tabolites) in BC tissue70,87,89,91,113.
By analyzing the results of the studies, 
some opposing results emerged. In particu-
lar, 39 (62%) investigations underline an as-
sociation between exposure to pesticides and 
FBC55,56,59,69-71,74-83,86,87,89,91,93-95,97-99,101,103,106-118; 
whereas the other 24 (38%) highlight the opposi
te56-59,60-68,72,73,84,85,88,90,92,96,100,102,104,105.
The association between FBC and pesticide 
exposure was asserted by 10 occupational and 29 
Figure 1. Flow diagram illustrating included and excluded 
studies in this systematic review.
Figure 2. Graphical map of the geographical distribution of the selected studies.
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Table I. Main characteristics of eligible studies of FBC.
     Population Age  
 Reference Exposure Study design Period observed (years) Country Conclusions
Davis et al55 Occupational Mortality cohort study 1968-1986 163 n.d. USA, Japan, UK, Probable association
      France, Italy, and 
      West Germany 
Wolff et al56 Environmental Case-control study 1985-1991 58 n.d. USA BC was strongly associated with 
       high DDE serum concentration
Krieger et al57 Environmental Case-control study 1960-1990 150 n.d. USA BC was not associated with DDE serum
       concentration
Wiklund and Dich58 Occupational Incidence cohort study 1971-1987 4747 n.d. Sweden No association with exposure to pesticides
Kettles et al59 Environmental Incidence cohort study 1991-1994 n.d. n.d. USA Relationship between exposure to
       triazine and FBC
Van ‘T Veer et al60 Environmental Case-control study 1991-1992 265 50-74 Germany, Netherlands, BC was not associated with DDE serum
      Northern Ireland,  concentration in postmenopausal women
      Switzerland, Spain 
López-Carrillo et al61 Environmental Case-control study 1994-1996 141 20-79 Mexico BC was not associated with DDE
       serum concentration
Hunter et al62 Environmental Case-control study 1989-1992 236 59 (43-69) USA BC was not associated with DDE
       serum concentration
Olaya-Contreras et al63 Environmental Case-control study 1995-1996 153 26-75 Colombia BC was associated with DDE 
       serum concentration
Petralia et al64 Occupational Incidence cohort study 1980-1984 69 n.d. China Exposure to pesticides was not related to
       the risk of FBC
Fleming et al65 Occupational Mortality cohort study 1975-1993 4 n.d. USA No association with exposure to pesticides
Mendonça et al66 Environmental Case-control study 1995-1996 177 57 (30-75) Brazil BC was not associated with DDE serum
       concentration
Fleming et al67 Occupational Incidence cohort study 1975-1993 26 n.d. USA No association with exposure to pesticides
Ward et al68 Environmental Case-control study 1975-1993 300 41.1±6.8 Norway BC was not associated with DDE serum
       concentration
Band et al69 Occupational Case-control study 1980-1995 2038 n.d. Canada Positive association with pesticide exposure
Aronson et al70 Environmental Case-control study 1995-1997 430 57.7 ± 11.6 Canada Association with Mirex and DDE
 and occupational     (cases)  concentration in breast adipose tissue
     53.9 ± 10.9   
     (controls)  
Continued
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Table I (Continued). Main characteristics of eligible studies of FBC.
     Population Age  
 Reference Exposure Study design Period observed (years) Country Conclusions
HØyer et al71 Environmental Cohort study 1976-1992 717 54.6) Denmark Possible association between organochlorine
     (mean  exposure and BC risk
Stellman et al72 Environmental Case-control study 1994-1996 1030 n.d. USA BC was not associated with DDE serum concentration
Millikan et al73 Environmental Case-control study 1993-1996 1730 50.8 USA BC was not associated with DDE serum concentration
     (23-74)  
Demers et al74 Environmental Case-control study 1994-1997 534 53 ± 10 Canada p,p′-DDE may increase BC aggressiveness
Duell et al75 Occupational Case-control study 1993-1996 1652 20-74 USA Positive association with pesticide exposure
Dolapsakis et al76 Occupational Cohort study 1988-1933 1053 40-75 Greece Exposed have a higher risk of breast lesions
Janssens et al77 Occupational Mortality cohort study 1985-1994 589 n.a. Belgium Positive association with pesticide exposure
Thomas et al78 Occupational Mortality cohort study 1980-1990 2548 15-65 USA Positive association with pesticide exposure
Mathur et al79 Environmental Case-control study 2002 185 21-70 India Positive association with pesticide exposure
Safi80 Environmental Observational study 1990-1999 796 0-65+ Palestine Association with exposure to pesticides
 and occupational      
Charlier et al81 Environmental Case-control study 1999-2000 409 54 ± 12 Belgium BC was associated with serum pesticide
       metabolite concentration
Brody et al82 Environmental Case-control study 1988-1995 2081 60-80 USA Increased risk only for pesticide applicators
 and occupational
O’Leary et al83 Environmental Case-control study 1980-1992 315 61.1 ± 11.4 USA Association with BC only in long-term resident 
       within 1 mile of hazard waste sites containing
       organochlorine pesticides
Muir et al84 Environmental Ecological study 1989-1991 n.d. > 45 UK No association between pesticide exposure and BC
Reynolds et al85 Environmental Cohort study 1995 133.479 40-59 USA No association between pesticide exposure and BC
Mills et al86 Environmental Case-control study 1988-2001 768 n.d. USA Chlordane, malathion, and 2,4-D were associated 
       with increased risk for BC (stronger in young women)
Raaschou-Nielsen et al87 Environmental Case-control study 1993-1997 818 57.4 ± 4.0 Denmark Correlation between estrogen receptor-negative
       BC and high organochlorine concentrations in 
       breast tissue
Engel et al88 Occupational Cohort study 1993-1997 30454 18-96 USA No association between pesticide exposure and BC
Zumbado et al89 Environmental Cohort study 1997-1998 783 6-75 Spain Possible association between estrogenic BC and 
       p,p′-DDT concentration
Continued
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Table I (Continued). Main characteristics of eligible studies of FBC.
     Population Age  
 Reference Exposure Study design Period observed (years) Country Conclusions
Alavanja et al90 Environmental Cohort study 1993-2002 52395 n.d. USA No association between pesticide exposure and BC
Waliszewski et al91 Environmental Case-control study 2004 254 49 Mexico Correlation between BC and organochlorine 
       concentrations in breast tissue.
Rubin et al92 Environmental Case-control study 1981-1987 126 < 54 USA BC was not associated with DDE serum 
       concentration
Khanjani et al93 Environmental Ecological study 1983-2002 797 n.d. Australia Limited association between BC and 
       organochlorine pesticide exposure
Teitelbau et al94 Environmental Case-control study 1993-1997 1508 n.d. USA Association between pesticide exposure and BC
Cohn et al95 Environmental A prospective nested 1959-1967 258 n.d. USA Exposure to p,p′-DDT early in life may increase
  case-control study     BC risk.
Itoh et al96 Environmental Case-control study 2001-2005 806 53.8 ± 0.5 Japan No association with serum pesticide metabolite concentration
Jacome et al97 Environmental Cohort study 2005-2008 110 20-35 Brazil Association between pesticide exposure and BC
Xu et al98 Environmental Cohort study 1999-2004 4172 20-75 USA BC was associated with serum organochlorine pesticide
       metabolite concentration
Zota et al99 Environmental Case-control study 1988-1995 1508 40-85 USA Moderate association between pesticide exposure and BC
Farooq et al100 Environmental Case-control study 1994-1996 1205 50-70 USA No association between pesticide exposure and BC
Waggoner et al101 Environmental Mortality cohort study 1993-2007 89656 n.a. USA Association between pesticide exposure and BC
Ashley-Martin et al102 Environmental Case-control study 1999-2002 828 54.8 ± 53.4-56.0 Canada No association between pesticide exposure and BC
El-Zaemey et al103 Environmental Case-control study 2009-2011 2912 30-75 Australia Association between pesticide exposure and BC at a
       young age of exposure
Holmes et al104 Environmental Case-control study 1999-2002 170 30-88 USA No association with serum pesticide metabolite concentration
El-Zaemey et al105 Environmental Case-control study 2009-2011 2912 30-75 Australia No association between pesticide exposure and BC
 and occupational      
Parrón et al106 Environmental Case-control study 1998-2005 34191 n.d. Spain Association between pesticide exposure and BC
Lerro et al107 Occupational Cohort study 1993-1997 30003 n.d. USA Association between pesticide exposure and BC
Cohn et al108 Environmental A prospective nested 1959-1967 472 n.d. USA Association between in utero DDT exposure and risk of 
  case-control study      BC in young women and possible association with more
       aggressive BC
Salerno et al109 Environmental Case-control study 2002-2009 12378 25-79 Italy Association between pesticide exposure and BC
Continued
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Table I (Continued). Main characteristics of eligible studies of FBC.
     Population Age  
 Reference Exposure Study design Period observed (years) Country Conclusions
He et al110 Environmental Case-control study 2015-2016 102 52.4 ± 10.6 China BC was associated with serum pesticide metabolite 
       concentration
Wielsøe et al111 Environmental Case-control study 2000-2003 161 52±9 Denmark BC was associated with blood pesticide metabolite
   2011-2014    concentration
Engel et al112 Occupational Cohort study 1993-1997 52394 n.d. USA Several organophosphate insecticides were associated
       with elevated BC risk
Eldakroory et al113 Environmental Cohort study 2014-2015 70 n.d. Egypt BC was associated with organochlorine pesticides in
       tissue specimens
Chang et al114 Environmental Cohort study 1996-2013 3141 n.d. Taiwan BC was associated with DDT exposure in childhood
Silva et al115 Environmental Case-control study 2017-2018 351 54.3  8.4 Brazil Women exposed to pesticides aged over 50 years and
     (cases)  who experienced early menarche had higher BC risk
     51.1 ± 10.6  
     (controls)  
Huang et al116 Environmental Case-control study 2014-2016 374 52.00 ± 9.89 China Association with p,p’-DDT, and p,p’-DDE and BC risk
     (cases)  
     48.64 ± 10.88   
     (controls) 
Cohn et al117 Environmental A prospective nested 1959-1967 585 n.d. USA p,p’-DDT is a risk factor for BC through age 54 years
  case-control study     
Cohn et al118 Environmental A prospective nested (1959-1967)  266 <50 years USA Association with p,p’-DDT, and p,p’-DDE and 
  case-control study 1998    BC risk
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Table II. Main characteristics of eligible studies of MBC.
     Population Age  
 Reference Exposure Study design Period observed (years) Country Conclusions
Cocco et al119 Occupational Case-control study 1985-1986 3 n.d. USA No association with exposure to pesticides
Fleming et al120 Occupational Mortality cohort study 1975-1993 0 / USA No cases of MBC were observed
Fleming et al121 Occupational Incidence of cohort study 1975-1993 2 n.d. USA No association with exposure to pesticides
Safi80 Environmental Observational study 1990-1999 5 2 (15-44 y) Palestine No association with exposure to pesticides
 and occupational    2 (55-64 y)  
     1 (+65 y)  
Fleming et al122 Occupational Mortality cohort study 1986-1994 0 / USA No cases of MBC were observed
Macfarlane et al123 Occupational Incidence cohort study 1991-2002 6 n.d. UK Gulf No association with exposure to pesticides
      war veterans
Villeneuve et al124 Occupational Cohort study 1995-1997 27 n.d. Europe No association with exposure to pesticides
Waggoner et al101 Environmental Mortality study 1993-1997 12 n.d. USA Negative association
 and occupational      
Parrón et al125 Environmental Case-control study 1998-2005 n.d. n.d. Spain No significant association
Salerno et al109 Environmental Case-control study 2002-2009 1 n.d. Italy Non-analyzable data
 and occupational      
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environmental studies. Beyond investigating the 
correlation between FBC and pesticide exposure, 
six focused on occupational exposure and 18 on 
environmental exposure.
By analyzing the subgroup of 30 reports that 
involved measuring pesticide metabolites in bi-
ological samples, it was observed that 19 (63%) 
indicated an association between pesticide me-
tabolites and FBC, and 11 (37%) showed no asso-
ciation. In particular, the investigations affirming 
a strong association were the most recent, and 
therefore were performed using more reliable 
analytical methods such as gas chromatogra-
phy-mass spectrometry and liquid chromatog-
raphy-mass spectrometry. Furthermore, studies 
that show a positive correlation between pesticide 
exposure and FBC highlight a strong association 
with the onset of carcinoma at a young age and 
with organochlorine pesticides. 
Among the studies in which a statistically sig-
nificant correlation was found between BC and 
pesticides, the latter were usually organochlorine 
pesticides.
Finally, it is possible to affirm that there can 
be a link between exposure to some classes of 
pesticides and the onset of FBC.
Male Breast Cancer
For this systematic review, 10 investigations 
were studied. Table II lists the main characteris-
tics of eligible studies for MBC. 
Cocco et al119 investigated the link between 
MBC risk and some occupational risk factors, 
including pesticides; they noticed a negative as-
sociation between occupational exposure to her-
bicides and other pesticides. 
Fleming et al120-122 conducted three studies on 
health outcomes in pesticide applicators, two on 
mortality120,122, and one on incidence121. No cases 
of MBC were reported in a mortality study120-122. 
A total of two cases were observed in the inci-
dence study121, but no correlation was found be-
tween pesticide exposure and MBC.
Safi80 described the association between 
chronic exposure to pesticides and recorded 
cases of cancer in an area where pesticides were 
used extensively. An incidence of 0.1% was 
reported, but also, in this case, no association 
between exposure to pesticides and MBC was 
established. 
An incidence cohort study among UK Gulf 
war veterans was carried out by Macfarlane et 
al123, who observed six cases of MBC, but no 
association was reported with pesticide exposure. 
Later, a specific study on MBC and occupa-
tional exposure to endocrine-disrupting chem-
icals, including pesticides, in eight European 
Countries was conducted by Villenueve et al124. 
Exposure to pesticides was not associated with 
MBC. 
Of the three mortality cohort studies in li-
censed pesticide users in the USA, in the two 
conducted by Fleming et al120-122, no cases of 
MBC were found, while in the study led by 
Wagoner et al101, 11 cases were found, but no 
association with previous exposure to pesticides 
was detected.
Environmental exposure to pesticides and can-
cer risk was evaluated by Parron et al125 but no 
significant association was found for MBC.
Finally, a population-based case-control study 
investigated the association between farming (a 
proxy for pesticide exposure) and cancer in Ita-
ly109, but they found only one case of MBC.
Therefore, in light of the results obtained, no 
study correlated pesticide exposure with MBC.
Discussion
Exposure to pesticides has become ubiquitous 
for workers and the general population because 
of their extensive use. The routes of pesticide 
exposure are different between occupational and 
environmental exposure, and it appears that the 
effects of exposure are also different for men and 
women.
Pesticides have been studied as a risk factor for 
many chronic-degenerative diseases126-140. 
From the studies analyzed, we can affirm that 
exposure to pesticides could be a risk factor for 
FBC, in particular in young women and in wom-
en who had menarche at a young age. In contrast, 
no association was found for MBC.
Organochlorine pesticides, including 
1,1’-(2,2,2-Trichloroethane-1,1-diyl)bis(4-chloro-
benzene) (DDT), were used extensively in the 
USA from the early 1940s until the 1960s for 
insect control (i.e., residential use) and outdoor 
(i.e., agriculture). The use of DDT peaked in the 
USA in the early 1960s and was prohibited in 
1972. Other organochlorines include pesticides 
used in lesser amounts, such as lindane and hexa-
chlorobenzene.
Organochlorine pesticides degrade slowly but 
are lipid-soluble; therefore, they bioaccumulate 
in the food chain and may be observed in human 
adipose tissue, blood, and breast milk. The most 
Pesticide exposure and gender discrepancy in breast cancer
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prevalent organochlorine residue usually found 
in human tissues is 1,1-dichloro-2,2-bis(p-chlo-
rophenyl)ethylene (DDE), the major metabolite 
of DDT132. 
DDE was found in the serum and breast adi-
pose tissue of patients with FBC in various stud-
ies and often correlated with FBC56,57,60-63,66,68,72-
75,81,92,96,98,104,108,110,111,116-118. However, in a lower 
number of studies, this association was not ob-
served70,87,89,91,113. 
The studies that do not support correlation are 
older papers and were therefore conducted with 
less precise analytical methods.
Recently, many research groups’ interest has 
been focused on the potential of various chem-
icals to act as “endocrine disruptors.” An endo-
crine disruptor is a compound that interferes with 
the endocrine system’s role by mimicking a hor-
mone, interrupting the effects of a hormone, or by 
stimulating or inhibiting the release or transport 
of hormones143. Several organochlorine pesticide 
metabolites, including DDE, are screened as en-
docrine disruptors because they showed slightly 
estrogenic or antiestrogenic activity in experi-
mental investigations144-145. Furthermore, carcino-
genic behaviors have been highlighted in animal 
models146-147.
In 1993, a case-control study carried out by 
Wolff et al56 in New York found the highest serum 
levels of DDE in FBC compared with a paired 
woman without BC. Since 1993, other research 
groups have attempted to confirm the associa-
tions observed in the Wolff et al study56, but these 
did not find the same association57,60-62,66,68,72,73,92,96. 
In a pooled analysis of other investiga-
tions63,70,74,86,87, the relative risks for FBC were 
significantly associated with women in the high-
est quintiles for DDE concentration.
Recent researches89,91,98,108-118 have highlighted 
the possibility that exposure to organochlorine 
pesticides may underly higher rates of FBC. 
Exposure to organochlorine pesticides appears 
to amplify the risk of FBC. A study carried out 
by Raaschou-Nielsen et al87 on FBC grouped by 
tumor characteristics such as estrogen receptor 
and progesterone receptor status, correlated high 
DDE concentrations with estrogen receptor-neg-
ative FBC. 
The etiology of estrogen receptor-negative 
FBC is unknown but is associated with a young 
age of onset and early menarche148,149.
Generally, MBC was highly estrogen recep-
tor positive compared with FBC. FBC has also 
been linked to estrogen receptor positivity, but 
this positivity appears to be inversely related to 
female fertility. Typically, it is known that older 
women are more likely to be estrogen recep-
tor-positive150.
The associations observed by Raaschou-Niel-
sen et al87 seem contrary to the extensively es-
tablished mechanism through which estrogens 
may cause BC by binding with estrogen recep-
tors151. The mechanism, therefore, remains un-
clear. Some organochlorine pesticides and several 
of their metabolites have been found to stimulate 
estrogen-like effects in exposed humans. Con-
sequently, they could be involved in endocrine 
pathologies connected with estrogenic effects, 
such as BC152-154. 
Cohn et al95 and other research groups155-158 
have provided more experimental evidence on 
the timing of environmental exposure to pes-
ticides during susceptible periods, also called 
“windows,” including in utero, and in child-
hood, puberty, and pregnancy, which can cause 
a change in the regulation of breast development 
that can provoke BC in adulthood. It is impossi-
ble to estimate the role of genetic susceptibility; 
however, from this review’s results, pesticide 
exposure and BC could be associated with in 
utero exposure and early BC. It is probable that 
pesticides may either provoke a non-germline 
genetic susceptibility or otherwise interact with 
an unknown genetic susceptibility. The recog-
nized association between BC and protracted 
exposure to estrogens suggests that environmen-
tal estrogens, such as organochlorine pesticides, 
could play a critical role in the cellular and mo-
lecular changes that happen throughout breast 
carcinogenesis. These alterations change healthy 
cells to latent tumor cells by shifting the genetic 
material that facilitates their proliferation159-164. 
Furthermore, there is evidence151 to support es-
trogen receptor-independent mechanisms in es-
trogen-mediated BC development through the 
production of genotoxic estrogen metabolites, 
which can provoke DNA damage and/or form 
DNA adducts151.
This finding provides the biological foundation 
to support the findings of the studies that link 
exposure to chlorinated pesticides to BC in the 
present systematic review. 
The current review provides a foundation for 
the link between exposure to chlorinated pesti-
cides and FBC.
The present study’s limitations include a loss 
of information about the exposure that occurred 
many years before the onset of BC; epidemiolog-
C. Ledda, M. Bracci, P. Lovreglio, P. Senia, M. Larrosa, B. Martínez-Jarreta, V. Rapisarda
2908
ical studies are conducted in different countries, 
which use different products and cultivation sys-
tems. Furthermore, certain studies do not report 
details on pesticide exposure or their concentra-
tion in biological fluids and/or tissues.
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